Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Quantifying the potential for dominant spread of SARS-CoV-2 variant B.1.351 in the United States

View ORCID ProfilePratha Sah, Thomas N. Vilches, Affan Shoukat, Abhishek Pandey, Meagan C. Fitzpatrick, Seyed M. Moghadas, Alison P. Galvani
doi: https://doi.org/10.1101/2021.05.10.21256996
Pratha Sah
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pratha Sah
Thomas N. Vilches
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA
2Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Affan Shoukat
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishek Pandey
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meagan C. Fitzpatrick
3Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W Baltimore St, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seyed M. Moghadas
2Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison P. Galvani
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alison.galvani@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: May 2021 to November 2023

AbstractFullPdf
May 2021112427208
Jun 2021139348
Jul 2021141518
Aug 20212962350
Sep 20211095135
Oct 20211194842
Nov 202190939
Dec 202174911
Jan 202254710
Feb 202266312
Mar 202255520
Apr 20224736
May 202245218
Jun 202244114
Jul 20223834
Aug 20223147
Sep 202249213
Oct 202240110
Nov 20223616
Dec 20222318
Jan 202328612
Feb 20232284
Mar 20232216
Apr 20233215
May 20231318
Jun 2023946
Jul 20231038
Aug 202321148
Sep 20232993
Oct 20231721
Nov 2023121618
Back to top
PreviousNext
Posted May 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Quantifying the potential for dominant spread of SARS-CoV-2 variant B.1.351 in the United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantifying the potential for dominant spread of SARS-CoV-2 variant B.1.351 in the United States
Pratha Sah, Thomas N. Vilches, Affan Shoukat, Abhishek Pandey, Meagan C. Fitzpatrick, Seyed M. Moghadas, Alison P. Galvani
medRxiv 2021.05.10.21256996; doi: https://doi.org/10.1101/2021.05.10.21256996
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Quantifying the potential for dominant spread of SARS-CoV-2 variant B.1.351 in the United States
Pratha Sah, Thomas N. Vilches, Affan Shoukat, Abhishek Pandey, Meagan C. Fitzpatrick, Seyed M. Moghadas, Alison P. Galvani
medRxiv 2021.05.10.21256996; doi: https://doi.org/10.1101/2021.05.10.21256996

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (576)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (183)
  • Emergency Medicine (330)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (696)
  • Epidemiology (11083)
  • Forensic Medicine (8)
  • Gastroenterology (619)
  • Genetic and Genomic Medicine (3156)
  • Geriatric Medicine (307)
  • Health Economics (560)
  • Health Informatics (2036)
  • Health Policy (861)
  • Health Systems and Quality Improvement (780)
  • Hematology (308)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2976)
  • Nursing (162)
  • Nutrition (461)
  • Obstetrics and Gynecology (588)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (474)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (200)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (909)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2773)
  • Public and Global Health (5581)
  • Radiology and Imaging (1089)
  • Rehabilitation Medicine and Physical Therapy (630)
  • Respiratory Medicine (755)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (286)
  • Surgery (342)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)